filmov
tv
Advocates Push For Easier Access To Opioid Agonists Treatments
Показать описание
President Biden is asking Congress to allocate almost 43 billion dollars to National Drug Control Program agencies, stating that would significantly fund "evidence-based prevention and harm services." The need for these services is growing but, one treatment called opioid agonists is proven especially hard to get.
Connect with NBC News Online!
#NBCNews #Opioid #HarmReduction
Connect with NBC News Online!
#NBCNews #Opioid #HarmReduction
Advocates Push For Easier Access To Opioid Agonists Treatments
Advocates push provinces for more equitable access to cancer treatments
Mental health advocates push for better access to treatment in Maine
Advocates push for increased doula access in New York State
Advocates push for federal approval of over-the-counter contraceptive
Advocates push for access to Representation Act passage
Advocates push for access to representation act passage
Advocates push for more safe injection sites in NY
Oral health advocates push for bill expanding access for dental hygiene
NEWS CONFERENCE: Advocates push to keep abortion pill access
Drug policy advocates push for drug decriminalization bill
🇺🇸 ♿ New York disability advocates push to improve transport access | Al Jazeera English
Advocates push for high-quality early care during Early Ed Month
Immigrant rights advocates push lawmakers to expand access to driver's licenses
Education advocates push for more public funding
Oregon advocates push for access to Alzheimer's treatments
Disability advocates push for access to COVID-19 vaccines in their community
Advocates push for better education programs in Georgia prisons
Maternal mental health advocates on the push for access to care after Duxbury tragedy
Advocates push for new braille literacy bill
Advocates in Louisiana push for more funding to go to early childhood education
Advocates push for more day care funding
Alzheimer's advocates push for drug coverage
Advocates push bill to expand access to driver’s licenses
Комментарии